According to 10x Genomics 's latest financial reports the company's total liabilities are $0.22 B. A companyโs total liabilities is the sum of all current and non-current debts and obligations.
Year | Total liabilities | Change |
---|---|---|
2023-12-31 | $0.22 B | 0.39% |
2022-12-31 | $0.22 B | 10.92% |
2021-12-31 | $0.20 B | 5.78% |
2020-12-31 | $0.19 B | 2.38% |
2019-12-31 | $0.18 B | -46.02% |
2018-12-31 | $0.34 B | 83.02% |
2017-12-31 | $0.18 B |
Company | Total liabilities | differencediff. | Country |
---|---|---|---|
Organovo ONVO | $2.69 M | -98.80% | ๐บ๐ธ USA |
Orchard Therapeutics
ORTX | $0.12 B | -45.56% | ๐ฌ๐ง UK |
Novavax NVAX | $2.51 B | 1,022.01% | ๐บ๐ธ USA |
Novocure
NVCR | $0.78 B | 249.68% | Jersey |